Loading...
Bienvenue sur la collection HAL du laboratoire B2PHI.
Le laboratoire Biostatistique, Biomathématique, Pharmacoépidémiologie et maladies Infectieuses est une unité mixte de recherche (UMR 1181) de l'INSERM, de l'Institut Pasteur et de l'Université de Versailles Saint-Quentin-en-Yvelines. Le laboratoire analyse les conséquences de l'exposition de la population aux anti-infectieux, en terme de risques d'infections, de résistance bactérienne aux antibiotiques et d'échappement vaccinal.
Derniers dépôts
Nombre de documents
91
Nombre de notices
33
Mots clés
Administrative area variations
Low-income countries
Antibiotics
Antibiotic consumption
Pregnancy
Simulation study
Ascending hierarchical classification
Burden
Prospective cohort study
Klebsiella pneumoniae
Épidémiologie
Schizophrenia
Adults
Public health
Stewardship
Chlamydia trachomatis
Anticoagulant therapy
16S rRNA gene sequencing
Mathematical modeling
Epidemiology
Treatment
Outcome
Anorexia nervosa
Pneumococcal meningitis
Venous thromboembolism
Accuracy
Source attribution
Modelling
Antibiotic resistance
Bacterial
Administrative health database
Acquisition
Long-term follow-up
Antibio-resistance
Neonates
Infection
Antimicrobial therapy
Cohort studies
B2PHI
Classification
Severe traumatic brain injury
Ascrs member survey
Direct-acting antivirals
Attributable risk
Modèle de Cox
Weighted Kaplan-Meier estimator
Pneumococcal conjugate vaccine
Cox model
Infections bactériennes
Pharmacoepidemiology
Long-term outcome
Breast cancer
Bacterial infections
Administrative healthcare database
Antimicrobial resistance
Piecewise constant hazards model
Memory
Impact
Accident vasculaire cérébral
Child
Hospital
Functional outcome
Pneumococcus
Health
Innovation
Executive functions
Attributable fraction
Bayesian inference
Agent-based model
Application de santé
France
Case-control study
Foodborne pathogen
Antimicrobial stewardship
Transmission
Prevention
Preterm birth
Longitudinal cohort study
Air pollution
Security
Logistic regression
Antifungal agents
Modélisation
Antibiorésistance
Traumatic brain injury
Mortality
Elderly
AP-HP
Activité de la maladie
Agent based model
Lung cancer
Smartphones
Antiretroviral therapy
Hepatitis C
Networks
Frequency-matching models
Adolescent
Screening
Influenza
Antimicrobial resistant bacteria